We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+10.46%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
10 Year Est. Return
AUM
$15.6B
AUM Growth
+$469M
Cap. Flow
-$728M
Cap. Flow %
-4.67%
Top 10 Hldgs %
19.64%
Holding
1,610
New
490
Increased
294
Reduced
373
Closed
440

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$174M
2
INTC icon
Intel
INTC
+$133M
3
IMMU
Immunomedics Inc
IMMU
+$130M
4
ABBV icon
AbbVie
ABBV
+$122M
5
NEE icon
NextEra Energy
NEE
+$108M

Sector Composition

Rank Sector Weight
1 Healthcare 27.77%
2 Technology 17.59%
3 Consumer Discretionary 13.24%
4 Industrials 9.9%
5 Financials 8.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLS icon
1051
Celestica
CLS
$39.2B
$329K ﹤0.01%
+47,800
New +$359K
CL icon
1052
Colgate-Palmolive
CL
$73.9B
$327K ﹤0.01%
4,243
-10,428
-71% -$795K
INBX
1053
DELISTED
Inhibrx, Inc. Common Stock
INBX
$324K ﹤0.01%
+17,992
New +$326K
NOAH
1054
Noah Holdings
NOAH
$594M
$323K ﹤0.01%
12,381
-1,720
-12% -$50.7K
WOW
1055
DELISTED
WideOpenWest
WOW
$323K ﹤0.01%
62,179
-81,969
-57% -$472K
SNY icon
1056
Sanofi
SNY
$105B
$319K ﹤0.01%
6,355
-48,559
-88% -$2.5M
BRK.B icon
1057
Berkshire Hathaway Class B
BRK.B
$1.12T
$317K ﹤0.01%
+1,487
New +$304K
MTOR
1058
DELISTED
MERITOR, Inc.
MTOR
$317K ﹤0.01%
+15,115
New +$340K
YALA
1059
Yalla Group
YALA
$817M
$316K ﹤0.01%
+45,000
New +$315K
PAND
1060
DELISTED
Pandion Therapeutics Inc. Common Stock
PAND
$316K ﹤0.01%
+27,569
New +$471K
WVE icon
1061
Wave Life Sciences
WVE
$1.19B
$313K ﹤0.01%
+36,762
New +$403K
BFX
1062
DELISTED
BowFlex Inc.
BFX
$312K ﹤0.01%
+18,193
New +$233K
NXGN
1063
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$312K ﹤0.01%
24,497
-26,828
-52% -$343K
FCN icon
1064
FTI Consulting
FCN
$4.18B
$311K ﹤0.01%
2,932
-26,459
-90% -$3.01M
SKX
1065
DELISTED
Skechers
SKX
$308K ﹤0.01%
+10,190
New +$304K
ADEA icon
1066
Adeia
ADEA
$3.08B
$305K ﹤0.01%
+100,484
New +$371K
OIS icon
1067
Oil States International
OIS
$536M
$305K ﹤0.01%
111,375
-89,726
-45% -$390K
LITE icon
1068
Lumentum
LITE
$62.2B
$304K ﹤0.01%
4,048
-26,302
-87% -$2.18M
ICFI icon
1069
ICF International
ICFI
$1.66B
$301K ﹤0.01%
+4,909
New +$326K
LNN icon
1070
Lindsay Corp
LNN
$1.19B
$297K ﹤0.01%
+3,077
New +$304K
MPT
1071
Medical Properties Trust
MPT
$2.47B
$297K ﹤0.01%
+16,850
New +$314K
MGRC icon
1072
McGrath RentCorp
MGRC
$2.99B
$294K ﹤0.01%
+4,936
New +$298K
BBT
1073
Beacon Financial Corp
BBT
$2.65B
$287K ﹤0.01%
28,476
-114,098
-80% -$1.12M
OXFD
1074
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$287K ﹤0.01%
+24,556
New +$326K
QTS
1075
DELISTED
QTS REALTY TRUST, INC.
QTS
$285K ﹤0.01%
+4,534
New +$302K

Similar funds

Marshall Wace North America's Q3 2020 Portfolio in Review

As of Q3 2020, Marshall Wace North America held 1,610 positions worth $15.6B, up 3.1% from $15.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Marshall Wace North America withdrew a net $728M in Q3 2020, closing 440 positions and reducing 373 holdings. Its most notable exit was Intel, an estimated $133M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 28% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Marshall Wace North America opened a new position in Keurig Dr Pepper worth $49.9M.

  • Marshall Wace North America's largest Q3 2020 buy was Keurig Dr Pepper: 1,808,999 shares worth $49.9M.
  • Marshall Wace North America added most to Danaher in Q3 2020, an estimated $141M increase.
  • Marshall Wace North America's biggest Q3 2020 reduction was UnitedHealth, cutting an estimated $174M.
  • Marshall Wace North America fully exited Intel in Q3 2020, selling an estimated $133M.
  • Marshall Wace North America's ten largest holdings make up 20% of its $15.6B portfolio in Q3 2020.
  • Marshall Wace North America opened 490 new positions and closed 440 in Q3 2020.
  • Marshall Wace North America's portfolio value rose 3.1% quarter-over-quarter to $15.6B.

Based on Marshall Wace North America's 13F filing for Q3 2020, filed 16 Nov 2020.